MSL
TECH icon

Mackay Shields LLC’s Bio-Techne TECH Stock Holding History

Mackay Shields LLC’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-23,056
Closed -$2.5M – 648
2022
Q1 		$2.5M Sell
23,056
-728
-3% -$75.1K 0.02% 509
2021
Q4 		$3.08M Sell
23,784
-308
-1% -$37.8K 0.03% 478
2021
Q3 		$2.92M Buy
+24,092
New +$2.93M 0.03% 466

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Mackay Shields LLC's TECH Position: Q2 2022 in Review

Mackay Shields LLC sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 23,056 shares — an estimated $2.5M sold.

Mackay Shields LLC first reported a position in TECH in Q3 2021 and held it in 3 quarters. The position peaked at $3.08M in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

  • Mackay Shields LLC reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 23,056 Bio-Techne shares in Q2 2022, an estimated $2.5M.
  • Mackay Shields LLC first reported a position in Bio-Techne in Q3 2021 and held it in 3 quarters.
  • Mackay Shields LLC's Bio-Techne position peaked at $3.08M in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.